Fig. 1.
Representative figures of c-MYC status detected by in situ hybridization (a and d) and immunohistochemistry (IHC; b and e), and of ß-catenin expression by IHC (c and f), in colorectal cancer patients. a Score 4 mRNA (40×); b c-MYC overexpression (40×); c Nuclear ß-catenin expression (40×); d Score 0 mRNA (40×); e No c-MYC expression (40×); f Membranous ß-catenin expression (40×)